Ray Mash was appointed general director in Ukraine for Zentiva, an international pharmaceutical company which is part of the Sanofi-Aventis group.
In his new position, Mash will be responsible for promoting the company’s drugs.
Before joining Zentiva, Mash headed operations of another pharmaceutical company in Ukraine, Sandoz.
Mash studied biology at Karl Marx University in Leipzig. He then received a Doctor of Natural Sciences degree from Alexander von Humboldt University in Berlin.
